Lanosterol 14-demethylase activity expressed in rat brain microsomes

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Cholesterol biosynthesis is essential for brain function.
• Sterol 14-demethylase (P45014DM or CYP51) is a key enzyme in the mevalonate pathway.
• Its presence and activity in brain tissue are not fully characterized.

Purpose of the Study:

• To confirm the presence and activity of sterol 14-demethylase in rat brain microsomes.
• To investigate the specific products and enzymatic characteristics of lanosterol demethylation in the brain.
• To compare the brain's sterol 14-demethylase activity and P450 composition with that of the liver.

Main Methods:

• Incubation of rat brain microsomes with lanosterol, NADPH, and molecular oxygen.
• Analysis of lanosterol metabolites using analytical techniques.
• Inhibition studies using carbon monoxide and ketoconazole.
• Quantification of enzyme activity and comparison with liver microsomes.

Main Results:

• Rat brain microsomes successfully converted lanosterol to 14-demethylated products.
• Enzyme activity was dependent on NADPH and oxygen, and inhibited by CO and ketoconazole, confirming P45014DM involvement.
• The ratio of P45014DM to total P450 was higher in brain microsomes compared to liver microsomes.

Conclusions:

• Sterol 14-demethylation, mediated by P45014DM, occurs in rat brain microsomes.
• This finding provides enzymatic evidence for the existence of the sterol biosynthesis pathway in the brain.
• The brain exhibits a distinct P450 composition regarding sterol 14-demethylase compared to the liver.